Literature DB >> 30282120

Transplant tourism complicated by life-threatening New Delhi metallo-β-lactamase-1 infection.

Jenell Stewart1, Gretchen Snoeyenbos Newman1, Rupali Jain1,2, Andrew Bryan3, Heather Berger3, Martin Montenovo4, Ramasamy Bakthavatsalam4, Catherine E Kling4, Lena Sibulesky4, Sherene Shalhub5, Ajit P Limaye1, Cynthia E Fisher1, Robert M Rakita1.   

Abstract

Transplant tourism, which is the practice of traveling to other countries for transplant, continues to be a major problem worldwide. We describe a patient who traveled to Pakistan and underwent commercial kidney transplant. He developed life-threatening infections from New Delhi metallo-β-lactamase-1-producing Enterobacter cloacae and Rhizopus oryzae, resulting in a necrotizing kidney allograft infection and subsequent external iliac artery rupture. He survived after a prolonged course of nonstandardized antimicrobial therapy, including a combination of aztreonam and ceftazidime-avibactam, and aggressive surgical debridement with allograft nephrectomy. The early timing of infection with these unusual organisms localized to the allograft suggests contamination and substandard care at the time of transplant. This case highlights the challenges of caring for these infections and serves as a cautionary tale for the potential complications of commercial transplant tourism.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  antibiotic: antibacterial; clinical research/practice; complication: infectious; infection and infectious agents - bacterial; infection and infectious agents - fungal; infectious disease; kidney transplantation/nephrology; organ sale/trade; organ transplantation in general

Year:  2018        PMID: 30282120      PMCID: PMC6436391          DOI: 10.1111/ajt.15136

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  20 in total

1.  In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015.

Authors:  James A Karlowsky; Krystyna M Kazmierczak; Boudewijn L M de Jonge; Meredith A Hackel; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Benjamin Davido; Lesly Fellous; Christine Lawrence; Virginie Maxime; Martin Rottman; Aurélien Dinh
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  The outcome of commercial kidney transplant tourism in Pakistan.

Authors:  Ninoslav Ivanovski; Jelka Masin; Irena Rambabova-Busljetic; Vlado Pusevski; Saso Dohcev; Ognen Ivanovski; Zivko Popov
Journal:  Clin Transplant       Date:  2011 Jan-Feb       Impact factor: 2.863

4.  Infectious risks of medical tourism.

Authors:  Roxanne Nelson
Journal:  Lancet Infect Dis       Date:  2014-08       Impact factor: 25.071

5.  Commercial kidney transplantation is an important risk factor in long-term kidney allograft survival.

Authors:  G V Ramesh Prasad; Sailesh Ananth; Sneha Palepu; Michael Huang; Michelle M Nash; Jeffrey S Zaltzman
Journal:  Kidney Int       Date:  2016-03-09       Impact factor: 10.612

6.  Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient.

Authors:  Maria F Mojica; Christopher P Ouellette; Amy Leber; M Brian Becknell; Monica I Ardura; Federico Perez; Masako Shimamura; Robert A Bonomo; Samuel L Aitken; Samuel A Shelburne
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

Review 7.  Invasive filamentous fungal infections associated with renal transplant tourism.

Authors:  S Shoham; F Hinestrosa; J Moore; S O'Donnell; M Ruiz; J Light
Journal:  Transpl Infect Dis       Date:  2010-02-16       Impact factor: 2.228

8.  Transplant tourism in the United States: a single-center experience.

Authors:  Jagbir Gill; Bhaskara R Madhira; David Gjertson; Gerald Lipshutz; J Michael Cecka; Phuong-Thu Pham; Alan Wilkinson; Suphamai Bunnapradist; Gabriel M Danovitch
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

9.  Equity in kidney transplantation: Policy change is only the first step.

Authors:  Allyson Hart; Rachel E Patzer
Journal:  Am J Transplant       Date:  2018-04-17       Impact factor: 8.086

10.  Mucormycosis in renal transplant recipients: review of 174 reported cases.

Authors:  Yan Song; Jianjun Qiao; Gaffi Giovanni; Guangjun Liu; Hao Yang; Jianyong Wu; Jianghua Chen
Journal:  BMC Infect Dis       Date:  2017-04-18       Impact factor: 3.090

View more
  3 in total

1.  Aztreonam Combination Therapy: An Answer to Metallo-β-Lactamase-Producing Gram-Negative Bacteria?

Authors:  Ryan K Shields; Yohei Doi
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

Review 2.  Infectious Complications of Transplant Tourism.

Authors:  Michele I Morris; Elmi Muller
Journal:  Curr Infect Dis Rep       Date:  2019-08-31       Impact factor: 3.725

Review 3.  Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians.

Authors:  Luigi Principe; Tommaso Lupia; Lilia Andriani; Floriana Campanile; Davide Carcione; Silvia Corcione; Francesco Giuseppe De Rosa; Roberto Luzzati; Giacomo Stroffolini; Marina Steyde; Giuliana Decorti; Stefano Di Bella
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.